Top Markets
Coin of the day
Promore Pharma AB (publ) Promore Pharma AB (publ)

Promore Pharma AB (publ)

PROMO
Rangering i aksjer #25506
Promore Pharma AB (publ) is a Swedish biopharmaceutical firm dedicated to... Promore Pharma AB (publ) is a Swedish biopharmaceutical firm dedicated to advancing peptide-based drug therapies. The company's development pipeline features PXL01, currently undergoing Phase IIa studies for its potential in preventing post-surgical adhesions and scars, mitigating dermal scarring, and aiding hand tendon repair. Another key asset, LL-37, is engaged in Phase IIb clinical trials to address venous leg ulcers, stimulate the healing of persistent wounds, and treat diabetic foot ulcers. Additionally, Promore Pharma has partnered with Fidia Farmaceutici S.p.A. for the production of hyaluronic acid syringes. Founded in 2002, the company, formerly known as Lipopeptide AB until its rebranding in January 2017, maintains its headquarters in Solna, Sweden.
Aksjekurs
$1.34
Sist synkronisert: 2024-02-14
Markedsverdi
$48.96M
Endring (1 dag)
-12.94%
Endring (1 år)
0.00%
Land
SE
Handel Promore Pharma AB (publ) (PROMO)

Kategori

Historikk for aksjesplitt for Promore Pharma AB (publ) (PROMO)
Aksjen Promore Pharma AB (publ) (symbol: PROMO) har gjennomgått totalt 0 aksjesplitt.
Den nyeste splittelsen skjedde Aug 21, 2026.
Én PROMO-aksje kjøpt før Aug 21, 2026 tilsvarer i dag 0 PROMO-aksjer.
Liste over aksjesplitt
År Splitt Multiplikator Kumulativ multiplikator
Ikke nok data for de angitte datoene.
Aksjesplitt for lignende selskaper eller konkurrenter
Selskap Antall aksjesplitt Kumulativ multiplikator Land
1 x2
US
0 -
NL
1 x3
AU
0 -
CH
0 -
US